Prime Medicine, Inc.
PRMEHealthcareBiotechnology
市值
$699.0M
CEO
Allan Reine
员工数
214
行业
Biotechnology
上市日期
2022-10-20
收录人数
15
近期高管变动
04/16上任Svetlana Makhni Chief Financial Officer and Principal Financial Officer07/15离任Jeremy Duffield, M.D. Ph.D., FRCP Chief Scientific Officer05/19resignedKeith Gottesdiener, M.D. President, Chief Executive Officer, Principal Executive Officer, Member of the Board of Directors, and all other officer and director positions held with Prime Medicine, Inc. and its subsidiaries01/05上任Allan Reine Chief Financial Officer and Principal Financial Officer05/11上任Jeff Marrazzo Class II Director, Member of the Compensation Committee
数据暂不可用